Clinical Trial Update: Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing WC2031 tablets to doxycycline (Vibramycin) for urogenital Chlamydia trachomatis infection has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Trachomatis Infection Urogenital

Drugs mentioned

• Vibramycin (doxycycline)
• WC2031

Snippet

Sponsor: Warner Chilcott | Conditions: Urogential Chlamydia Trachomatis Infection | Phase 3 | Status: COMPLETED | Results posted: 2012-01-27